Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Janac sold 11,452 shares of the stock in a transaction on Monday, October 5th. The shares were sold at an average price of $24.27, for a total value of $277,940.04. Following the completion of the transaction, the chief executive officer directly owned 154,337 shares of the company’s stock, valued at approximately $3,745,758.99. This represents a 6.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
K Charles Janac also recently made the following trade(s):
- On Friday, October 2nd, K Janac sold 9,359 shares of Arteris stock. The stock was sold at an average price of $24.64, for a total transaction of $230,605.76.
- On Thursday, October 1st, K Janac sold 100,000 shares of Arteris stock. The stock was sold at an average price of $23.82, for a total transaction of $2,382,000.00.
- On Tuesday, September 1st, K Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $20.75, for a total transaction of $2,075,000.00.
- On Tuesday, August 4th, K Janac sold 26,106 shares of Arteris stock. The stock was sold at an average price of $31.97, for a total transaction of $834,608.82.
- On Monday, August 3rd, K Janac sold 73,894 shares of Arteris stock. The stock was sold at an average price of $30.00, for a total transaction of $2,216,820.00.
Arteris Price Performance
AIP stock traded up $0.16 during mid-day trading on Tuesday, reaching $24.13. The company’s stock had a trading volume of 476,272 shares, compared to its average volume of 728,847. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.03. The company’s 50 day moving average is $24.73 and its two-hundred day moving average is $28.61. Arteris, Inc. has a fifty-two week low of $12.06 and a fifty-two week high of $50.26. The stock has a market cap of $1.19 billion, a PE ratio of -27.74 and a beta of 1.90.
Key Arteris News
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
- Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
- Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on AIP. Weiss Ratings raised shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Rosenblatt Securities reaffirmed a “buy” rating and set a $38.00 target price on shares of Arteris in a research note on Friday, August 7th. Oppenheimer began coverage on shares of Arteris in a research note on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price target for the company. Roth Capital began coverage on shares of Arteris in a report on Tuesday, August 4th. They set a “buy” rating and a $40.00 price target for the company. Finally, Craig Hallum began coverage on shares of Arteris in a research report on Monday, September 21st. They set a “buy” rating and a $30.00 price target on the stock. Six equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $39.43.
Check Out Our Latest Stock Analysis on AIP
Institutional Trading of Arteris
Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. purchased a new stake in Arteris in the 2nd quarter valued at about $160,129,000. Needham Investment Management LLC increased its position in shares of Arteris by 2.6% during the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock valued at $52,878,000 after acquiring an additional 86,500 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock valued at $24,305,000 after acquiring an additional 1,897 shares during the period. Granahan Investment Management LLC raised its stake in shares of Arteris by 201.0% in the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock valued at $11,723,000 after acquiring an additional 476,181 shares during the period. Finally, Algert Global LLC acquired a new position in shares of Arteris in the 2nd quarter worth approximately $11,602,000. 64.36% of the stock is owned by institutional investors and hedge funds.
Arteris Company Profile
Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.
The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.
Featured Articles
- Five stocks we like better than Arteris
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
